TY - JOUR
T1 - Chronic pain following laparoscopic living-donor nephrectomy
T2 - Prevalence and impact on quality of life
AU - Bruintjes, Moira H D
AU - van Helden, Esmee V
AU - de Vries, Marjan
AU - Wirken, Lieke
AU - Evers, Andrea W M
AU - van Middendorp, Henriët
AU - Kloke, Heinrich
AU - d'Ancona, Frank C H
AU - Langenhuijsen, Johan F
AU - Steegers, Monique A H
AU - Warlé, Michiel C
N1 - © 2019 The Authors American Journal of Transplantation published by Wiley Periodicals, Inc. on behalf of The American Society of Transplantation and the American Society of Transplant Surgeons.
PY - 2019/10
Y1 - 2019/10
N2 - Chronic postsurgical pain (CPSP) following laparoscopic donor nephrectomy (LDN) is a disregarded topic. In this cross-sectional study, all consecutive patients who underwent an LDN at the Radboud University Medical Center (Radboudumc; 2003-2016) were approached for participation. Five hundred twelve living kidney donors were included and asked to complete two questionnaires, including the McGill Pain Questionnaire and the RAND Short Form-36 Health Status Inventory (RAND SF-36) regarding their health-related quality of life (HRQoL). The mean prevalence of CPSP following LDN was 5.7%, with a mean follow-up time of 6 years. Possible predictors of CPSP following LDN are severe early postoperative pain, previous abdominal surgery, and preexisting backache. The RAND SF-36 revealed an impaired HRQoL in patients with CPSP when compared to patients without CPSP. In conclusion, this study revealed that the prevalence of CPSP following LDN is substantial. Given the possible association between the presence of CPSP and impaired HRQoL scores, living kidney donors should be well informed in the preoperative phase about the risk of CPSP.
AB - Chronic postsurgical pain (CPSP) following laparoscopic donor nephrectomy (LDN) is a disregarded topic. In this cross-sectional study, all consecutive patients who underwent an LDN at the Radboud University Medical Center (Radboudumc; 2003-2016) were approached for participation. Five hundred twelve living kidney donors were included and asked to complete two questionnaires, including the McGill Pain Questionnaire and the RAND Short Form-36 Health Status Inventory (RAND SF-36) regarding their health-related quality of life (HRQoL). The mean prevalence of CPSP following LDN was 5.7%, with a mean follow-up time of 6 years. Possible predictors of CPSP following LDN are severe early postoperative pain, previous abdominal surgery, and preexisting backache. The RAND SF-36 revealed an impaired HRQoL in patients with CPSP when compared to patients without CPSP. In conclusion, this study revealed that the prevalence of CPSP following LDN is substantial. Given the possible association between the presence of CPSP and impaired HRQoL scores, living kidney donors should be well informed in the preoperative phase about the risk of CPSP.
U2 - https://doi.org/10.1111/ajt.15350
DO - https://doi.org/10.1111/ajt.15350
M3 - Article
C2 - 30868731
SN - 1600-6135
VL - 19
SP - 2825
EP - 2832
JO - American Journal of Transplantation
JF - American Journal of Transplantation
IS - 10
ER -